Status:

UNKNOWN

Dry Needling vs Injection in Patients With Temporomandibular Disorders

Lead Sponsor:

Josue Fernandez Carnero

Conditions:

Temporomandibular Disorders

Eligibility:

All Genders

18-60 years

Phase:

NA

Brief Summary

The main objective is to compare the effectiveness of dry needling in improving pain and disability versus placebo, and versus infiltration, in patients with myofascial temporomandibular dysfunction i...

Eligibility Criteria

Inclusion

  • Subjects aged between 18 and 60 years.
  • Pain of more than 6 weeks of evolution in the craniofacial region.
  • TMD with origin in the masticatory musculature according to the "DC-TMD" criteria.

Exclusion

  • Previous injection or dry needling intervention (3 months) on the masseter muscle.
  • Arthrogenous TMD.
  • History of trauma, infection in the temporomandibular joint in the last 6 months.
  • Coagulation disorders.
  • Pregnancy.

Key Trial Info

Start Date :

November 23 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 15 2024

Estimated Enrollment :

64 Patients enrolled

Trial Details

Trial ID

NCT04726683

Start Date

November 23 2020

End Date

December 15 2024

Last Update

November 15 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Clínica Universitaria de la Universidad Rey Juan Carlos

Alcorcón, Madrid, Spain, 28922